Omnicell, Inc. Increases U.K. Commitment and Presence with Acquisition of Longtime Partner Avantec Healthcare Limited
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Omnicell (OMCL) Completes Avantec Healthcare Acquisition; Boosts FY15 Revenue Outlook
April 30, 2015 8:21 AM EDTOmnicell (NASDAQ: OMCL) has completed its acquisition of Avantec Healthcare Limited based in Lancing, West Sussex, United Kingdom.
Avantec develops medication and supply automation products that complement Omnicell solutions for configurations uniquely suited to the U.K. marketplace, and has been the exclusive U.K. distributor of Omnicell solutions since 2005. Avantec has installed over 900 systems in 80 National Health Service (NHS) and private hospitals.
This acquisition further demonstrates Omnicell's commitment to supporting the U.K. marketplace. The company purchased U.K. medication adherence packaging provider Surgichem Limited in 2014, and recently completed its acquisition of... More
